| Financial Year |
March 31 2023 |
| Monetary Funds |
1,367,896,852.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
926,199.34 |
| Accounts Receivable |
294,554,040.93 |
| Advances to Suppliers |
26,699,481.08 |
| Other Receivables |
14,829,907.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
272,540,157.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
59,042,512.15 |
| Total Current Assets |
2,036,489,150.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
808,521,028.64 |
| Under-construction Projects |
402,434,444.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
285,799,986.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
38,568,415.72 |
| Deferred Income Tax Assets |
49,266,948.58 |
| Other Non-Current Assets |
107,302,874.13 |
| Sub-Total of Non-Current Assets |
1,741,350,217.40 |
| Total Assets |
3,777,839,367.97 |
| Short-Term Loans |
80,080,208.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
294,343,048.33 |
| Accounts Received In Advance |
598,170.22 |
| Employee Compensation Payable |
52,144,436.50 |
| Taxes Payable |
52,741,439.66 |
| Interest Payable |
195,205.48 |
| Dividend Payable |
-- |
| Other payables |
66,780,815.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,249,602.60 |
| Other Current Liabilities |
3,297,307.62 |
| Sub-Total of Current Liabilities |
590,832,313.29 |
| Long-term Loans |
-- |
| Bonds Payable |
694,978,347.60 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
294,445.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
743,221,884.06 |
| Total Liabilities |
1,334,054,197.35 |
| Paid-In Capital(Or Share Stock) |
169,340,000.00 |
| Capital Surplus |
1,292,423,509.22 |
| Surplus Reserve |
67,970,639.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
659,399,959.51 |
| Minority Stockholder's Interest |
8,683,876.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,435,101,294.30 |
| Owner's Equity（Stockholder's Equity） |
2,443,785,170.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,777,839,367.97 |
